Compare TECH & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | WLK |
|---|---|---|
| Founded | 1976 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 10.3B |
| IPO Year | 1995 | 2004 |
| Metric | TECH | WLK |
|---|---|---|
| Price | $72.00 | $78.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $71.82 | ★ $106.87 |
| AVG Volume (30 Days) | ★ 3.7M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 0.62% | ★ 1.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | $1,219,635,000.00 | ★ $11,170,000,000.00 |
| Revenue This Year | $2.49 | $5.51 |
| Revenue Next Year | $6.40 | $3.74 |
| P/E Ratio | $89.00 | ★ N/A |
| Revenue Growth | ★ 5.23 | N/A |
| 52 Week Low | $43.20 | $56.33 |
| 52 Week High | $72.37 | $124.23 |
| Indicator | TECH | WLK |
|---|---|---|
| Relative Strength Index (RSI) | 73.83 | 54.54 |
| Support Level | $70.49 | $77.58 |
| Resistance Level | $72.22 | $78.76 |
| Average True Range (ATR) | 0.32 | 2.78 |
| MACD | -0.59 | 0.75 |
| Stochastic Oscillator | 66.12 | 79.69 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.